Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: The Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) study

American Journal of Kidney Diseases

Volumn 56, Issue 2, 2010, Pages 348-358

  Shafi, Tariq ^a,b   Jaar, Bernard G ^a,b,c,d   Plantinga, Laura C ^e   Fink, Nancy E ^a,c   Sadler, John H ^f   Parekh, Rulan S ^a,c,g,h   Powe, Neil R ^a,c,e   Coresh, Josef ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d NEPHROLOGY CENTER OF MARYLAND   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Independent Dialysis Foundation   (United States)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

End stage renal disease; hemodialysis; inflammation; mortality; quality of life; residual kidney function

Indexed keywords

C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROPOIETIN; INTERLEUKIN 6; PHOSPHATE BINDING AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT ASSESSMENT; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RESIDUAL URINE; SELF REPORT; URINE VOLUME; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; KIDNEY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; URINE;

AGED; CARDIOVASCULAR DISEASES; ERYTHROPOIETIN; FEMALE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RENAL DIALYSIS; URINE;

EID: 77955901447     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.03.020     Document Type: Article

References (39)

1. J. Perl, and J.M. Bargman The importance of residual kidney function for patients on dialysis: a critical review Am J Kidney Dis. 53 6 2009 1068 1081
2. A.Y.M. Wang, and K.N. Lai The importance of residual renal function in dialysis patients Kidney Int. 69 10 2006 1726 1732
3. C.J. Konings, J.P. Kooman, and M. Schonck, et al. Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study Nephrol Dial Transplant. 18 4 2003 797 803
4. F. Termorshuizen, F.W. Dekker, J.G. van Manen, J.C. Korevaar, E.W. Boeschoten, and R.T. Krediet Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2 J Am Soc Nephrol. 15 4 2004 1061 1070
5. A.Y.-M. Wang, M. Wang, and J. Woo, et al. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients Kidney Int. 62 2 2002 639 647
6. J.P. Tian, F.H. Du, L.T. Cheng, and T. Wang Residual renal function and arterial stiffness mediated the blood pressure change during interdialytic weight gain in hemodialysis patients Hemodial Int. 13 4 2009 479 486
7. A.Y. Wang The "heart" of peritoneal dialysis Perit Dial Int. 27 suppl 2 2007 S228 S232
8. D. Shemin, A.G. Bostom, P. Laliberty, and L.D. Dworkin Residual renal function and mortality risk in hemodialysis patients Am J Kidney Dis. 38 1 2001 85 90
9. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy, update 2006 Am J Kidney Dis 48 suppl 1 2006 S2 S90
10. L.M. Moist, F.K. Port, and S.M. Orzol, et al. Predictors of loss of residual renal function among new dialysis patients J Am Soc Nephrol. 11 3 2000 556 564
11. N.R. Powe, M.J. Klag, J.H. Sadler, et al. CHOICE Study Choices for Healthy Outcomes in Caring for End Stage Renal Disease Semin Dial. 9 1996 9 11
12. B.G. Jaar, J. Coresh, and L.C. Plantinga, et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease Ann Intern Med. 143 3 2005 174 183
13. A.W. Wu, N.E. Fink, and K.A. Cagney, et al. Developing a health-related quality-of-life measure for end-stage renal disease: the CHOICE Health Experience Questionnaire Am J Kidney Dis. 37 1 2001 11 21
14. D.C. Miskulin, K.B. Meyer, and N.V. Athienites, et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study Choices for Healthy Outcomes in Caring for End-Stage Renal Disease Am J Kidney Dis. 39 2 2002 324 336
15. V.A. Nicolaos, C.M. Dana, and F. Gladys, et al. Comorbidity assessment in hemodialysis and peritoneal dialysis using the Index of Coexistent Disease Semin Dial. 13 5 2000 320 326
16. J.T. Daugirdas Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error J Am Soc Nephrol. 4 5 1993 1205 1213
17. J.M. Bargman, K.E. Thorpe, and D.N. Churchill Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA Study J Am Soc Nephrol. 12 10 2001 2158 2162
18. F. Termorshuizen, J.C. Korevaar, F.W. Dekker, J.G. van Manen, E.W. Boeschoten, and R.T. Krediet The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2 Am J Kidney Dis. 41 6 2003 1293 1302
19. R. Paniagua, D. Amato, and E. Vonesh, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial J Am Soc Nephrol. 13 5 2002 1307 1320
20. E. Vilar, D. Wellsted, S.M. Chandna, R.N. Greenwood, and K. Farrington Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose Nephrol Dial Transplant. 24 8 2009 2502 2510
21. J.C. Longenecker, J. Coresh, and N.R. Powe, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study J Am Soc Nephrol. 13 7 2002 1918 1927
22. R.N. Foley, P.S. Parfrey, and J.D. Harnett, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy Kidney Int. 47 1 1995 186 192
23. R.N. Foley, P.S. Parfrey, J.D. Harnett, G.M. Kent, D.C. Murray, and P.E. Barre The prognostic importance of left ventricular geometry in uremic cardiomyopathy J Am Soc Nephrol. 5 12 1995 2024 2031
24. K. Ates, G. Nergizoglu, and K. Keven, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients Kidney Int. 60 2 2001 767 776
25. K. Kalantar-Zadeh, D.L. Regidor, and C.P. Kovesdy Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis Circulation 119 5 2009 671 679
26. N.M. Pham, N.S. Recht, T.H. Hostetter, and T.W. Meyer Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis Clin J Am Soc Nephrol. 3 1 2008 85 90
27. B. Bammens, P. Evenepoel, K. Verbeke, and Y. Vanrenterghem Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms Kidney Int. 64 6 2003 2238 2243
28. A.K. Cheung, M.V. Rocco, and G. Yan, et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO Study J Am Soc Nephrol. 17 2 2006 546 555
29. R. Pecoits-Filho, O. Heimburger, and P. Barany, et al. Associations between circulating inflammatory markers and residual renal function in CRF patients Am J Kidney Dis. 41 6 2003 1212 1218
30. A.Y. Wang, C.W. Lam, and M. Wang, et al. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients Am J Kidney Dis. 45 4 2005 715 729
31. M. Arici, and J. Walls End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int. 59 2 2001 407 414
32. Y. Liu, J. Coresh, and J.A. Eustace, et al. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition JAMA 291 4 2004 451 459
33. H. Schiffl, S.M. Lang, and R. Fischer Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients Nephrol Dial Transplant. 17 10 2002 1814 1818
34. V. Panichi, U. Maggiore, and D. Taccola, et al. Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients Nephrol Dial Transplant. 19 5 2004 1154 1160
35. V. Panichi, G.M. Rizza, and S. Paoletti, et al. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies Results from the RISCAVID Study Nephrol Dial Transplant. 23 7 2008 2337 2343
36. J.B. Wetmore, D.H. Lovett, and A.M. Hung, et al. Associations of interleukin-6, C-reactive protein and serum amyloid A with mortality in haemodialysis patients Nephrology (Carlton) 13 7 2008 593 600
37. M.O. Leavitt Secretary of Health and Human Services report to Congress: a design for a bundled end-stage renal disease prospective payment system http://www.cms.hhs.gov/ESRDGeneralInformation/Downloads/ESRDReportToCongress. pdf 2008 Accessed July 30, 2009
38. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy Am J Kidney Dis. 48 suppl 1 2006 S98 S129
39. J.L. Bragg-Gresham, R.B. Fissell, and N.A. Mason, et al. Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS) Am J Kidney Dis. 49 3 2007 426 431